Study to Assess the Efficacy and Safety of Budesonide (PT008) in Adult Subjects With Mild to Moderate Persistent Asthma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Paul Dorinsky, MD, FCCP
Pearl Therapeutics, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
41 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Pearl Therapeutics Study Site
Athens, Alabama, United States
- Pearl Therapeutics Study Site
Birmingham, Alabama, United States
- Pearl Therapeutics Study Site
Foley, Alabama, United States
- Pearl Therapeutics
Los Angeles, California, United States
- Pearl Therapeutics Study Site
Los Angeles, California, United States
- Pearl Therapeutics Study Site
Rolling Hills Estates, California, United States
- Pearl Therapeutics Study Site
San Diego, California, United States
- Pearl Therapeutics Study Site
Stockton, California, United States
- Pearl Therapeutics Study Site
Clearwater, Florida, United States
- Pearl Therapeutics Study Site
Clermont, Florida, United States
- Pearl Therapeutics Study Site
Miami, Florida, United States
- Pearl Therapeutics Study Site
Orlando, Florida, United States
- Pearl Therapeutics Study Site
Ormond Beach, Florida, United States
- Pearl Therapeutics Study Site
Saint Cloud, Florida, United States
- Pearl Therapeutics Study Site
Sebring, Florida, United States
- Pearl Therapeutics Study Site
Tampa, Florida, United States
- Pearl Therapeutics Study Site
Blue Island, Illinois, United States
- Pearl Therapeutics Study Site
North Dartmouth, Massachusetts, United States
- Pearl Therapeutics Study Site
Hazelwood, Missouri, United States
- Pearl Therapeutics Study Site
Skillman, New Jersey, United States
- Pearl Therapeutics Study Site
Charlotte, North Carolina, United States
- Pearl Therapeutics Study Site
Winston-Salem, North Carolina, United States
- Pearl Therapeutics Study Site
Cincinnati, Ohio, United States
- Pearl Therapeutics Study Site
Columbus, Ohio, United States
- Pearl Therapeutics Study Site
Dayton, Ohio, United States
- Pearl Therapeutics Study Site
Middleburg Heights, Ohio, United States
- Pearl Therapeutics Study Site
Oregon, Ohio, United States
- Pearl Therapeutics Study Site
Sylvania, Ohio, United States
- Pearl Therapeutics Study Site
Toledo, Ohio, United States
- Pearl Therapeutics Study Site
Oklahoma City, Oklahoma, United States
- Pearl Therapeutics Study Site
Lake Oswego, Oregon, United States
- Pearl Therapeutics Study Site
Medford, Oregon, United States
- Pearl Therapeutics Study Site
Greenville, South Carolina, United States
- Pearl Therapeutics Study Site
Spartanburg, South Carolina, United States
- Pearl Therapeutics Study Site
Rapid City, South Dakota, United States
- Pearl Therapeutics Study Site
Tullahoma, Tennessee, United States
- Pearl Therapeutics Study Site
El Paso, Texas, United States
- Pearl Therapeutics Study Site
Houston, Texas, United States
- Pearl Therapeutics Study Site
Plano, Texas, United States
- Pearl Therapeutics Study Site
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Apr 2014
- Primary completion
- 1 Sept 2015
- Completion
- 4 Sept 2015
- Last update posted
- 6 Jun 2017
- Registered enrollment
- 147
- Registry id
- NCT02105012
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.